New antiarrhythmic drugs for atrial flutter and atrial fibrillation a conceptual breakthrough at last?

被引：12
|
作者：
Cosío, FG
Delpón, E
机构：
[1] Univ Madrid, Hosp Getafe, Serv Cardiol, Madrid, Spain
[2] Univ Complutense Madrid, Dept Pharmacol, Madrid, Spain
来源：
CIRCULATION | 2002年 / 105卷 / 03期
关键词：
D O I：
10.1161/circ.105.3.276
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：276 / 278
页数：3
相关论文
共 50 条
  • [31] Non-antiarrhythmic drugs in atrial fibrillation: A review of non-antiarrhythmic agents in prevention of atrial fibrillation
    Lally, James A.
    Gnall, Eric M.
    Seltzer, Jonathan
    Kowey, Peter R.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (11) : 1222 - 1228
  • [32] Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
    Maykov, E. B.
    Yuricheva, Yu. A.
    Mironov, N. Yu.
    Sokolov, S. F.
    Golitsyn, S. P.
    Rozenshtraukh, L. V.
    Chazov, E. I.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (01) : 38 - 48
  • [33] New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance
    LaPointe, NMA
    Pamer, CA
    Kramer, JM
    PHARMACOTHERAPY, 2003, 23 (10): : 1316 - 1321
  • [34] New antiarrhythmic targets in atrial fibrillation
    Voigt, Niels
    Heijman, Jordi
    Dobrev, Dobromir
    FUTURE CARDIOLOGY, 2015, 11 (06) : 645 - 654
  • [35] Preferential effects of antiarrhythmic drugs on the low right atrial isthmus in human atrial flutter
    Tai, CT
    Chen, SA
    Chiang, CE
    Chang, MS
    CIRCULATION, 1997, 96 (08) : 1457 - 1457
  • [36] IS IN-HOSPITAL INITIATION OF CLASS IA OR IC ANTIARRHYTHMIC DRUGS IN PATIENTS WITH ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER JUSTIFIED
    HELGUERA, ME
    PINSKI, SL
    GUPTA, P
    WILKOFF, BL
    CASTLE, LW
    CIRCULATION, 1993, 88 (04) : 446 - 446
  • [37] Transcatheter ablation of typical atrial flutter in patients with atrial fibrillation treated with antiarrhythmic drugs - One year follow-up
    Pytkowski, M
    Maciag, A
    Kraska, A
    Kowalik, I
    Malczewska, B
    Szwed, H
    EUROPACE 2001, 2001, : 113 - 118
  • [38] Atrial flutter after CABG: antiarrhythmic drugs or transoesphageal pacing?
    Kalejs, O
    Lacis, R
    Harlamovs, V
    Jirgensons, J
    Sakne, S
    Strelnieks, A
    EUROPEAN HEART JOURNAL, 2000, 21 : 88 - 88
  • [39] The interrelationship between atrial fibrillation and atrial fibrillation and atrial flutter
    Waldo, AL
    PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 48 (01) : 41 - 56
  • [40] Focus on IV ibutilide: A new antiarrhythmic agent for the acute treatment of atrial fibrillation and flutter
    Chen, BP
    Chow, MSS
    Kluger, J
    FORMULARY, 1996, 31 (07) : 570 - &
12345